Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
622.50    2.50 (0.40%)
Bid:
622.50
Ask:
623.50
Spread: 1.00 (0.161%)
Market Cap: £2.88b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

Trading Statement

6 Oct 2022 07:00

RNS Number : 9483B
RS Group PLC
06 October 2022
 

 

6 October 2022, 7.00am

 

RS Group plc today issues a trading update for its first half ended 30 September 2022 ahead of publishing half-year results on 3 November 2022

 

A STRONG TRADING PERFORMANCE SUPPORTED BY ONGOING MARKET SHARE GAINS

 

LINDSLEY RUTH, CHIEF EXECUTIVE OFFICER, COMMENTED: "We continue to grow market share, reflecting the strength of our people, our purpose-led culture and differentiated offer. Our active inventory management to support availability, coupled with a more commercial operating model and improved pricing, lead us to expect full year revenue and adjusted profit to be slightly ahead of consensus expectations1. We remain mindful of the more challenging economic backdrop but believe we have built a strong, sustainable business that can withstand external headwinds and outperform the market. As such, we will continue to invest in our product and service solutions capability and customer experience to support our Journey to Greatness and drive profitable growth, capitalising on the significant market share opportunity we see."

 

 

Like-for-like revenue growth2

Region

Q1 to June 2022

Q2 to Sept 2022

H1 to Sept 2022

EMEA

16%

15%

15%

Americas

24%

19%

21%

Asia Pacific

13%

6%

10%

Group

18%

15%

16%

 

Q2 revenue performance is underpinned by volume growth and reflects ongoing market share expansion

· Like-for-like revenue growth of 15% despite tough comparatives, macro headwinds and slowing economic growth.

· We estimate a 4% benefit to second quarter revenue from foreign exchange.

· Our industrial product ranges outperformed our electronics range, the former growing like-for-like revenue by 21%.

· EMEA delivered broad-based growth across the region, reflecting an improving customer mix and growth in share of customer wallet; evidenced by increased average order value and frequency.

· Americas' performance benefited from focused sales and digital campaigns and high customer demand. A strong inventory position supported availability to drive market share gains. Our acquisition of Risoul remains on track and we anticipate, subject to review by the Mexican competition authorities, it will be completed by late November.

· Asia Pacific's revenue growth was impacted by lack of single-board computing product. Excluding OKdo5, revenue growth was 14%. Our industrial product ranges continue to outperform our electronics range.

· Our own-brand, RS PRO, grew like-for-like revenue by 21%, due to greater availability and website personalisation.

· Web like-for-like revenue increased by 15%, with digital participation of 63%.

Ongoing margin and cost optimisation are offsetting cost inflation and operational investment

· Improvements to our pricing and discount model continued to benefit the gross margin.

· We have tightened our inventory commitments, ensuring investment is focused and reflects customer demand.

· Increased inflationary cost pressures are being offset by strong control and positive operating leverage.

· We continue to invest in operational and sustainable improvements to support our Journey to Greatness6.

Our first half performance leads us to expect full year profit to be slightly ahead of consensus estimates

Given our strong trading performance year to date we expect our full year revenue and adjusted profit before tax to be slightly ahead of current consensus estimates1, albeit with a greater first half weighting than historically delivered. While we are expecting slower economic growth in the second half, we have several financial levers we can employ, if appropriate, to protect our profit. However, we remain confident in the strength of our people and proposition, especially in this environment, in driving further market share gains to generate stronger revenue and high-quality profitable growth.

 

 

 

 

 

Notes:

1. Consensus for the year ending 31 March 2023 is revenue of £2,858 million, adjusted operating profit of £364.9 million and adjusted profit before tax of £357.7 million. Source: rsgroup.com/investors/analyst-coverage.

2. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions and the effects of changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2021/22 is converted at 2022/23 average exchange rates for the period.  

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2022 for euro and US dollar were €1.176 and $1.366 respectively. Average exchange rates for the half year ended 30 September 2022 for euro and US dollar were €1.174 and $1.216 respectively. Every 1 cent movement in the euro has a c. £1.8 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar has a c. £0.7 million impact on annual adjusted profit before tax. 

4. We expect to see a negative impact of around £11 million on revenue from fewer trading days in 2022/23 compared to 2021/22.  

5. OKdo is our technology solutions business focused on single-board computing, Internet of Things and education.

6. We have been awarded a platinum medal by EcoVadis, the independent provider of global sustainability ratings used by many large organisations to help support sustainable purchasing decisions.

 

LEI: 549300KVXDURRKVWR37

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Tulchan Communications

020 7353 4200

 

Conference call details

There will be a conference call for analysts and investors today at 8.00am UK time. A recording of the conference will be provided shortly after the event via the investor relations page of the RS Group website: www.rsgroup.com/investors  

Please find the registration link below to join digitally. It is advisable to pre-register early to avoid any delays in joining the conference call. To ask a question, participants will need to be connected by phone.

Pre-registration link: https://webcast.openbriefing.com/rsgroup-oct22/

Participant dial in number:

United Kingdom: 020 3936 2999

All other locations: +44 20 3936 2999

Or dial-in online: www.incommuk.com/customers/online

Access code: 653274

Conference call timing

Date: Thursday, 6 October 2022

Time: 8.00am UK time

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPESEELAFFA
Date   Source Headline
17th Jun 202610:00 amRNSHolding(s) in Company
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 202612:00 pmRNSAnnual Financial Report and Notice of AGM
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 202610:00 amRNSDirector/PDMR Shareholding
2nd Jun 20263:55 pmRNSDirector Declaration
1st Jun 202612:43 pmRNSHolding(s) in Company
1st Jun 20269:44 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:01 amRNSCommencement of Share Buyback Programme
20th May 20267:00 amRNSFinal Results
1st Apr 20265:06 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSPre-Close Trading Update
3rd Mar 20267:00 amRNSAcquisition of BPX Group
6th Jan 20264:00 pmRNSDirector/PDMR Shareholding
12th Dec 20253:14 pmRNSDirectorate change
4th Dec 202510:00 amRNSDirector/PDMR Shareholding
20th Nov 20254:20 pmRNSReplacement Holding(s) in Company
20th Nov 20253:30 pmRNSHolding(s) in Company
7th Nov 20253:56 pmRNSHolding(s) in Company
6th Nov 20257:00 amRNSHalf-year Financial Report
1st Sep 20254:30 pmRNSHolding(s) in Company
12th Aug 20254:30 pmRNSHolding(s) in Company
8th Aug 20254:00 pmRNSHolding(s) in Company
1st Aug 202511:02 amRNSBlock listing Interim Review
21st Jul 20254:00 pmRNSDirector/PDMR Shareholding
17th Jul 20253:15 pmRNSResult of AGM
17th Jul 20257:00 amRNSAGM Update
4th Jul 202510:00 amRNSDirectorate Change - Chair of Audit Committee
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jun 20259:00 amRNSDirector/PDMR Shareholding
18th Jun 20254:30 pmRNSDirector/PDMR Shareholding
10th Jun 202511:00 amRNSHolding(s) in Company
9th Jun 202512:00 pmRNSAnnual Financial Report and Notice of AGM
6th Jun 20252:00 pmRNSDirector/PDMR Shareholding
29th May 202510:00 amRNSDirector/PDMR Shareholding
21st May 20257:00 amRNSFinal Results
23rd Apr 20254:30 pmRNSDirector/PDMR Shareholding
28th Mar 20252:30 pmRNSDirector/PDMR Shareholding
26th Mar 202511:00 amRNSDirector/PDMR Shareholding
21st Feb 202510:00 amRNSDirectorate Change
3rd Feb 202510:39 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNS3rd Quarter Trading Update
8th Jan 20259:13 amRNSDirector Declaration
7th Jan 20252:38 pmRNSDirector Declaration
29th Nov 20248:30 amRNSDirectorate Change
7th Nov 20247:00 amRNSHalf-year Report
1st Oct 20249:46 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSInvestor Event: The RS Opportunity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.